Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Longitudinal Blinded Observational Diagnostic Study - Addition of microRNA Blood Test to Lung Cancer Screening Low Dose CT

NCT03452514 is registered in ClinicalTrials.gov with Hummingbird Diagnostics as lead sponsor.

NCT NCT03452514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03452514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Longitudinal Blinded Observational Diagnostic Study - Addition of microRNA Blood Test to Lung Cancer Screening Low Dose CT
Lead sponsor
Hummingbird Diagnostics
Phase
Observational
Overall status
Completed
Start date
November 1, 2017
Completion date
September 15, 2020
Enrollment
479 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer